To determine if the investigated polymorphism affects the plasma level of sHLA-G in glioma patients, we compared the level of sHLA-G in patients with different variants of the HLA-G 14 ins/del genotypes; however, the differences were not statistically significant. Here, HLA-G is linked to central nervous system cancer.